SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Booker T. Washington Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientBooker T. Washington
Date of birth1856-04-05
IdentifiersMRN HR-NI017-SYN-TD; SSN (made up) 000-17-2284
Document date2026-11-01
AuthorLorraine Whitfield, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for headaches, fatigue, and a very high blood pressure. Concerns: Frontal headaches every week or so, palpitations, and fatigue are cutting into his workday; Worried about blurred reading vision and getting up at night to urinate; Wants a plan that fits a heavy travel schedule. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1915-05-04activeS
Losartan 50 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1915-05-04 to 1915-05-11completedS
Losartan 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1915-05-11activeS
Dapagliflozin 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1915-05-11activeS
Chlorthalidone 25 mg oral tablet, one-half tablet (12.5 mg) by mouth dailyOne-half tablet by mouth dailyOral route1915-06-01activeS
Atorvastatin 20 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1915-05-04activeS

Procedures

ProcedureDatesStatusEvidence
12-lead electrocardiogram: sinus rhythm with left ventricular hypertrophy by voltage1915-05-04 to 1915-05-04completedS
Dilated funduscopic examination: arteriolar narrowing and arteriovenous nicking in both eyes; no hemorrhages, exudates, or papilledema1915-05-04 to 1915-05-04completedS
Renal ultrasound: both kidneys small (9.4 and 9.6 cm) and echogenic, without hydronephrosis1915-05-11 to 1915-05-11completedS
Transthoracic echocardiography: concentric left ventricular hypertrophy, ejection fraction 60 percent1915-05-11 to 1915-05-11completedS

Immunizations

DateVaccineStatusEvidence
1914-10-20Influenza vaccine, 1914-1915 seasoncompletedS
1915-05-11Pneumococcal conjugate vaccine PCV20completedS
1915-05-11Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS
1915-06-29Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS
1908-09-16Tdap vaccinecompletedS
1915-09-21Influenza vaccine, 1915-1916 seasoncompletedS
1915-09-21Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1911Assault in New York City with two large scalp lacerations and a torn ear; recovered without apparent sequelaeD (CLM-0005)
1911Chronic indigestion, worse when traveling; several days of treatment at the Battle Creek Sanitarium in 1911D (CLM-0005)

Family History

RelativeConditionAge at deathEvidence
motherDied in Malden, West Virginia, in 1876 (other accounts give 1874); cause not recorded in the cited sourceD (CLM-0003)

Health Concerns

ConcernStatusEvidence
Frontal headaches every week or so, palpitations, and fatigue are cutting into his workdayactiveS
Worried about blurred reading vision and getting up at night to urinateactiveS
Wants a plan that fits a heavy travel scheduleactiveS

Assessment

Most recent measures: Sodium [Moles/volume] in Serum or Plasma 137 on 1915-08-10; Potassium [Moles/volume] in Serum or Plasma 4.7 on 1915-08-10; Carbon dioxide, total [Moles/volume] in Serum or Plasma 23 on 1915-08-10; Urea nitrogen [Mass/volume] in Serum or Plasma 37 on 1915-08-10; Creatinine [Mass/volume] in Serum or Plasma 2.4 on 1915-08-10; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1910)/1.73 sq M 30 on 1915-08-10; Glucose [Mass/volume] in Serum or Plasma 94 on 1915-08-10; Calcium [Mass/volume] in Serum or Plasma 9.2 on 1915-10-26; Phosphate [Mass/volume] in Serum or Plasma 4 on 1915-10-26; Parathyrin.intact [Mass/volume] in Serum or Plasma 78 on 1915-10-26; Hemoglobin [Mass/volume] in Blood 12.8 on 1915-10-26; Ferritin [Mass/volume] in Serum or Plasma 210 on 1915-05-04; Iron saturation [Mass Fraction] in Serum or Plasma 26 on 1915-05-04; Thyrotropin [Units/volume] in Serum or Plasma 1.8 on 1915-05-04; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 1915-05-04; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 138 on 1915-05-04; Albumin/Creatinine [Mass Ratio] in Urine 240 on 1915-10-26; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 1915-09-21; Kidney failure 2-year risk [Likelihood] by KFRE 6.5 on 1915-10-26; Kidney failure 5-year risk [Likelihood] by KFRE 18.8 on 1915-10-26; Left ventricular Ejection fraction 60 on 1915-05-11; Total score [AUDIT-C] 1 on 1915-09-21 [S]

Strengths and supports: Supports: spouse, adult children, and long-time colleagues who urged him to be seen [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Severe hypertension with hypertensive kidney disease; synthetic modern diagnosis linked to the documented 1804 blood pressure of 220/150activeconfirmed I12.9S — Synthetic active diagnosis for the teaching episode; the 1915 findings remain D and the retrospective diagnosis remains R.
Chronic kidney disease stage G3b A3 (severely increased albuminuria), attributed to hypertensive nephrosclerosisactiveconfirmed N18.32S — Synthetic diagnosis supported by small echogenic kidneys and albuminuria; linked to the documented 1915 diagnosis of Bright's disease.
Hypertensive retinopathy, both eyes, without papilledemaactiveconfirmed H35.033S — Synthetic funduscopic finding that echoes the documented failing vision.
Mild anemia of chronic kidney disease, iron replete; monitoractiveconfirmed D63.1S — Synthetic finding from the baseline hemoglobin and iron studies.
Hyperlipidemiaactiveconfirmed E78.5S — Synthetic finding from the baseline LDL cholesterol.
Acute lumbar muscle strain after lifting, resolved without NSAIDs or imagingresolvedconfirmed S39.012AS — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1915-05-04Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1915-05-04Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
1915-05-04Carbon dioxide, total [Moles/volume] in Serum or Plasma21mmol/L22-29 mmol/LLowS
1915-05-04Urea nitrogen [Mass/volume] in Serum or Plasma34mg/dL6-24 mg/dLHighS
1915-05-04Creatinine [Mass/volume] in Serum or Plasma2.1mg/dL0.74-1.35 mg/dLHighS
1915-05-04Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1910)/1.73 sq M36mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
1915-05-04Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
1915-05-04Calcium [Mass/volume] in Serum or Plasma9.1mg/dL8.6-10.3 mg/dLNormalS
1915-05-04Phosphate [Mass/volume] in Serum or Plasma4.2mg/dL2.5-4.5 mg/dLNormalS
1915-05-04Parathyrin.intact [Mass/volume] in Serum or Plasma92pg/mL15-65 pg/mLHighS
1915-05-04Hemoglobin [Mass/volume] in Blood12.6g/dL13.2-16.6 g/dLLowS
1915-05-04Ferritin [Mass/volume] in Serum or Plasma210ng/mL30-400 ng/mLNormalS
1915-05-04Iron saturation [Mass Fraction] in Serum or Plasma26%20-50%NormalS
1915-05-04Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.45-4.5 mIU/LNormalS
1915-05-04Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
1915-05-04Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation138mg/dL<=99 mg/dLHighS
1915-05-04Albumin/Creatinine [Mass Ratio] in Urine820mg/g<=30 mg/gHighS
1915-05-04Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1915-05-11Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
1915-05-11Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
1915-05-11Carbon dioxide, total [Moles/volume] in Serum or Plasma22mmol/L22-29 mmol/LNormalS
1915-05-11Urea nitrogen [Mass/volume] in Serum or Plasma36mg/dL6-24 mg/dLHighS
1915-05-11Creatinine [Mass/volume] in Serum or Plasma2.2mg/dL0.74-1.35 mg/dLHighS
1915-05-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1910)/1.73 sq M34mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
1915-05-11Glucose [Mass/volume] in Serum or Plasma95mg/dL70-99 mg/dLNormalS
1915-06-01Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
1915-06-01Potassium [Moles/volume] in Serum or Plasma4.9mmol/L3.5-5.1 mmol/LNormalS
1915-06-01Carbon dioxide, total [Moles/volume] in Serum or Plasma22mmol/L22-29 mmol/LNormalS
1915-06-01Urea nitrogen [Mass/volume] in Serum or Plasma38mg/dL6-24 mg/dLHighS
1915-06-01Creatinine [Mass/volume] in Serum or Plasma2.4mg/dL0.74-1.35 mg/dLHighS
1915-06-01Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1910)/1.73 sq M30mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
1915-06-01Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
1915-06-29Sodium [Moles/volume] in Serum or Plasma135mmol/L135-145 mmol/LNormalS
1915-06-29Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1915-06-29Carbon dioxide, total [Moles/volume] in Serum or Plasma23mmol/L22-29 mmol/LNormalS
1915-06-29Urea nitrogen [Mass/volume] in Serum or Plasma36mg/dL6-24 mg/dLHighS
1915-06-29Creatinine [Mass/volume] in Serum or Plasma2.4mg/dL0.74-1.35 mg/dLHighS
1915-06-29Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1910)/1.73 sq M30mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
1915-06-29Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
1915-06-29Albumin/Creatinine [Mass Ratio] in Urine360mg/g<=30 mg/gHighS
1915-10-26Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
1915-10-26Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
1915-10-26Carbon dioxide, total [Moles/volume] in Serum or Plasma23mmol/L22-29 mmol/LNormalS
1915-10-26Urea nitrogen [Mass/volume] in Serum or Plasma34mg/dL6-24 mg/dLHighS
1915-10-26Creatinine [Mass/volume] in Serum or Plasma2.3mg/dL0.74-1.35 mg/dLHighS
1915-10-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1910)/1.73 sq M32mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
1915-10-26Glucose [Mass/volume] in Serum or Plasma93mg/dL70-99 mg/dLNormalS
1915-10-26Calcium [Mass/volume] in Serum or Plasma9.2mg/dL8.6-10.3 mg/dLNormalS
1915-10-26Phosphate [Mass/volume] in Serum or Plasma4mg/dL2.5-4.5 mg/dLNormalS
1915-10-26Parathyrin.intact [Mass/volume] in Serum or Plasma78pg/mL15-65 pg/mLHighS
1915-10-26Hemoglobin [Mass/volume] in Blood12.8g/dL13.2-16.6 g/dLLowS
1915-10-26Albumin/Creatinine [Mass Ratio] in Urine240mg/g<=30 mg/gHighS
1915-10-26Kidney failure 2-year risk [Likelihood] by KFRE6.5%S
1915-10-26Kidney failure 5-year risk [Likelihood] by KFRE18.8%S
1915-10-26Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
1915-05-11Left ventricular Ejection fraction60%50-70%NormalS
1915-08-10Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
1915-08-10Potassium [Moles/volume] in Serum or Plasma4.7mmol/L3.5-5.1 mmol/LNormalS
1915-08-10Carbon dioxide, total [Moles/volume] in Serum or Plasma23mmol/L22-29 mmol/LNormalS
1915-08-10Urea nitrogen [Mass/volume] in Serum or Plasma37mg/dL6-24 mg/dLHighS
1915-08-10Creatinine [Mass/volume] in Serum or Plasma2.4mg/dL0.74-1.35 mg/dLHighS
1915-08-10Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1910)/1.73 sq M30mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
1915-08-10Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
1915-09-21Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
1915-09-21Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1915-05-04Body height170cmS
1915-05-04Body weight71kgS
1915-05-04Body mass index (BMI) [Ratio]24.6kg/m2S
1915-05-04Systolic blood pressure212mm[Hg]S
1915-05-04Diastolic blood pressure128mm[Hg]S
1915-05-04Heart rate88/minS
1915-05-04Respiratory rate16/minS
1915-05-04Body temperature36.8CelS
1915-05-04Oxygen saturation in Arterial blood by Pulse oximetry97%S
1915-05-11Body height170cmS
1915-05-11Body weight71kgS
1915-05-11Body mass index (BMI) [Ratio]24.6kg/m2S
1915-05-11Systolic blood pressure172mm[Hg]S
1915-05-11Diastolic blood pressure104mm[Hg]S
1915-05-11Heart rate82/minS
1915-05-11Respiratory rate16/minS
1915-05-11Body temperature36.7CelS
1915-05-11Oxygen saturation in Arterial blood by Pulse oximetry98%S
1915-06-01Body height170cmS
1915-06-01Body weight70kgS
1915-06-01Body mass index (BMI) [Ratio]24.2kg/m2S
1915-06-01Systolic blood pressure148mm[Hg]S
1915-06-01Diastolic blood pressure92mm[Hg]S
1915-06-01Heart rate78/minS
1915-06-01Respiratory rate16/minS
1915-06-01Body temperature36.8CelS
1915-06-01Oxygen saturation in Arterial blood by Pulse oximetry98%S
1915-06-29Body height170cmS
1915-06-29Body weight70kgS
1915-06-29Body mass index (BMI) [Ratio]24.2kg/m2S
1915-06-29Systolic blood pressure128mm[Hg]S
1915-06-29Diastolic blood pressure80mm[Hg]S
1915-06-29Heart rate74/minS
1915-06-29Respiratory rate14/minS
1915-06-29Body temperature36.7CelS
1915-06-29Oxygen saturation in Arterial blood by Pulse oximetry98%S
1915-10-26Body height170cmS
1915-10-26Body weight70.5kgS
1915-10-26Body mass index (BMI) [Ratio]24.4kg/m2S
1915-10-26Systolic blood pressure118mm[Hg]S
1915-10-26Diastolic blood pressure76mm[Hg]S
1915-10-26Heart rate72/minS
1915-10-26Respiratory rate14/minS
1915-10-26Body temperature36.6CelS
1915-10-26Oxygen saturation in Arterial blood by Pulse oximetry98%S
1915-08-10Body height170cmS
1915-08-10Body weight70.3kgS
1915-08-10Body mass index (BMI) [Ratio]24.3kg/m2S
1915-08-10Systolic blood pressure132mm[Hg]S
1915-08-10Diastolic blood pressure82mm[Hg]S
1915-08-10Heart rate80/minS
1915-08-10Respiratory rate14/minS
1915-08-10Body temperature36.7CelS
1915-08-10Oxygen saturation in Arterial blood by Pulse oximetry98%S
1915-09-21Body height170cmS
1915-09-21Body weight70.4kgS
1915-09-21Body mass index (BMI) [Ratio]24.4kg/m2S
1915-09-21Systolic blood pressure122mm[Hg]S
1915-09-21Diastolic blood pressure76mm[Hg]S
1915-09-21Heart rate72/minS
1915-09-21Respiratory rate14/minS
1915-09-21Body temperature36.6CelS
1915-09-21Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
1915-05-04Primary care visit for headaches, fatigue, and a very high blood pressurefinishedS
1915-05-11One-week blood pressure and kidney safety check with nephrology consultationfinishedS
1915-06-01Three-week check after losartan titration and dapagliflozin startfinishedS
1915-06-29Four-week check after adding chlorthalidonefinishedS
1915-10-26Six-month blood pressure and chronic kidney disease reviewfinishedS
1915-08-10Same-day sick visit for low back painfinishedS
1915-09-21Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Treat severe hypertension without acute target-organ damage as an outpatient: start losartan and amlodipine together, check home blood pressure twice daily, and go to the emergency department for chest pain, shortness of breath, weakness, confusion, or vision losscompletedGL-HTN-2025S
Nephrology referral for eGFR below 60 with severely increased albuminuria (UACR above 300 mg/g) and stage 2 hypertensioncompletedGL-KDIGO-CKD-2024, GL-CMID-2026S
Titrate losartan to the maximum tolerated dose and add an SGLT2 inhibitor for CKD with UACR of at least 200 mg/g; accept a creatinine rise of up to 30 percentcompletedGL-KDIGO-CKD-2024, GL-KDIGO-BP-2021S
Add chlorthalidone if blood pressure stays above target on two agents; avoid NSAIDs and review every medication dose for kidney functioncompletedGL-KDIGO-BP-2021, GL-HTN-2025S
Check potassium and creatinine one to four weeks after each renin-angiotensin, SGLT2 inhibitor, or diuretic change; then eGFR and UACR about three times a year for G3b A3, hemoglobin at least yearly, and calcium, phosphate, and PTH every six to twelve months; recalculate the kidney failure risk yearlycompletedGL-CMID-2026, GL-KDIGO-CKD-2024S
Moderate-intensity statin for an adult aged 50 or older with eGFR below 60; no routine repeat LDLcompletedGL-KDIGO-CKD-2024, GL-CMID-2026S
Sodium below 2 g a day with a plan for meals while traveling; at least 150 minutes of activity a weekcompletedGL-KDIGO-CKD-2024, GL-HTN-2025S
Annual dilated eye examination for hypertensive retinopathy; pneumococcal and hepatitis B vaccination for chronic kidney diseasecompletedGL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Lower blood pressure below 130/80 within two months1915-06-29completedBlood pressure 128/80 on four medicinesS
Reach a standardized office systolic pressure below 120 when tolerated by the six-month review1915-10-26completedBlood pressure 118/76 without dizzinessS
Reduce the urine albumin-creatinine ratio by at least 30 percent by the six-month review1915-10-26completedUACR fell from 820 to 240 mg/gS
Keep eGFR decline after starting therapy within 30 percent and stable thereafter1915-10-26completedeGFR 36 at baseline, 30 on full therapy, 32 at six monthsS

Functional Status

Mental Status